News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Toray Industries, Japan Tobacco, Torii Pharmaceutical Co. To Collaborate In Development And Distribution Of TRK-820 Antipruritus Drug For Hemodialysis Patients


10/19/2005 5:13:03 PM

Tokyo (JCNN) - Toray Industries, Japan Tobacco and Torii Pharmaceutical jointly announced that they have entered into a contract for TRK-820, a selective kappa opioid receptor agonist.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES